West Pharmaceutical Services, Inc. (WST)
NYSE: WST · IEX Real-Time Price · USD
342.79
-12.85 (-3.61%)
May 20, 2024, 3:59 PM EDT - Market closed

WST Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 1994
Revenue
2,9502,8872,8322,1471,840
Upgrade
Revenue Growth (YoY)
2.18%1.95%31.89%16.69%7.13%
Upgrade
Cost of Revenue
1,8211,7511,6561,3791,234
Upgrade
Gross Profit
1,1291,1361,176767.8605.7
Upgrade
Selling, General & Admin
353.4316.9362.8302272.7
Upgrade
Research & Development
68.458.552.846.938.9
Upgrade
Other Operating Expenses
31.426.87.912-2.5
Upgrade
Operating Expenses
453.2402.2423.5360.9309.1
Upgrade
Operating Income
676734752.3406.9296.6
Upgrade
Interest Expense / Income
97.98.28.28.5
Upgrade
Other Expense / Income
-48.725.5-24.9-20-12.6
Upgrade
Pretax Income
715.7700.6769418.7300.7
Upgrade
Income Tax
122.3114.7107.272.559
Upgrade
Net Income
593.4585.9661.8346.2241.7
Upgrade
Net Income Growth
1.28%-11.47%91.16%43.24%16.82%
Upgrade
Shares Outstanding (Basic)
7474747474
Upgrade
Shares Outstanding (Diluted)
7576767675
Upgrade
Shares Change
-0.66%-0.66%0.66%0.53%-
Upgrade
EPS (Basic)
7.987.878.894.683.27
Upgrade
EPS (Diluted)
7.887.738.674.573.21
Upgrade
EPS Growth
1.94%-10.84%89.72%42.37%17.15%
Upgrade
Free Cash Flow
414.5439.4330.6298.1240.8
Upgrade
Free Cash Flow Per Share
5.585.914.444.033.25
Upgrade
Dividend Per Share
0.7700.7300.6900.6500.610
Upgrade
Dividend Growth
5.48%5.80%6.15%6.56%7.02%
Upgrade
Gross Margin
38.28%39.36%41.52%35.76%32.92%
Upgrade
Operating Margin
22.92%25.43%26.57%18.95%16.12%
Upgrade
Profit Margin
20.12%20.30%23.37%16.13%13.14%
Upgrade
Free Cash Flow Margin
14.05%15.22%11.68%13.89%13.09%
Upgrade
Effective Tax Rate
17.09%16.37%13.94%17.32%19.62%
Upgrade
EBITDA
862829.1899.5536412.6
Upgrade
EBITDA Margin
29.22%28.72%31.77%24.97%22.43%
Upgrade
Depreciation & Amortization
137.3120.6122.3109.1103.4
Upgrade
EBIT
724.7708.5777.2426.9309.2
Upgrade
EBIT Margin
24.57%24.54%27.45%19.88%16.81%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).